Novel panel identifies toxins linked to asthma and GI diseases: Melissa Snyder, Ph.D.
Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of eosinophil-derived neurotoxins.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:32)
Could you provide us with a little bit of your background?
(01:12)
Could you give us an overview of this test and a summary of the assay?
(01:40)
What kind of patients should expect to have this test ordered?
(04:11)
Are other tests available that identify EDN activation in patients?
(05:11)
How do you envision physicians using this test to treat patients?
(06:32)
Can you expand on how the test is used in patient treatment?